Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,014Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12care4

02 1Medartuum AB

03 1NORIDEM ENTERPRISES LTD

04 1NOVARTIS FARMA SPA

05 1Novartis Pharma Schweiz AG

06 2Olon Spa

07 2Orifarm AB

08 1Orifarm AS

09 2Paranova Pharmaceutical AB

10 1Pharmachim AB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Deferoxamine Mesylate

Brand Name :

Dosage Form : Lyophilizate

Dosage Strength : 500MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info : Available Dossier- US-EU-RoW

Registration Country : Italy

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Deferoxamine Mesylate

Brand Name :

Dosage Form : Lyophilizate

Dosage Strength : 2000MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

deferoxaminmesilat

Brand Name : Desferin

Dosage Form : POWDER FOR INJECTION / INFUSION

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

deferoxaminmesilat

Brand Name : Desferal

Dosage Form : POWDER FOR INJECTION / INFUSION

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Deferoxamine

Brand Name : Desferal

Dosage Form : Powder for injection/infusion fluid, resolution

Dosage Strength : 500 mg

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

deferoxaminmesilat

Brand Name : Desferal

Dosage Form : POWDER FOR INJECTION / INFUSION

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

deferoxaminmesilat

Brand Name : Desferal

Dosage Form : POWDER FOR INJECTION / INFUSION

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

Pharmachim AB

Country
2024 ACI Convention
Not Confirmed
arrow

Pharmachim AB

Country
arrow
2024 ACI Convention
Not Confirmed

deferoxaminmesilat

Brand Name : Desferal

Dosage Form : POWDER FOR INJECTION / INFUSION

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

Medartuum AB

Country
2024 ACI Convention
Not Confirmed
arrow

Medartuum AB

Country
arrow
2024 ACI Convention
Not Confirmed

deferoxaminmesilat

Brand Name : Desferal

Dosage Form : POWDER FOR INJECTION / INFUSION

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

2care4

Country
2024 ACI Convention
Not Confirmed
arrow

2care4

Country
arrow
2024 ACI Convention
Not Confirmed

Deferoxamine

Brand Name : Desferal

Dosage Form : Powder for injection/infusion fluid, resolution

Dosage Strength : 500 mg

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank